Intranasal Epinephrine (NS-002)

Access to Epinephrine is a priority for reducing Anaphylaxis. Intranasal Epinephrine aimed at assisting in acute emergency situations. 

nasusphrma taffix

Medical need

Definition: Severe allergic type 1 reaction. Life threatening.
Prevalence: 1.5 % of the US population suffer an event each
(500,000 cases annually)
Cost of treatment 4 B annually
Mortality rates 1.2 % per episode, 30 % recurrence risk lifetime
Epinephrine IM or IV is the first line treatment.

nasusphrma taffix
nasusphrma taffix
nasusphrma taffix
nasusphrma taffix
nasusphrma taffix

Contact us for more information

To request more information , please submit your contact details below: